Downregulation of Human Kallikrein 10 (KLK10/NES1) by CpG Island Hypermethylation in Breast, Ovarian and Prostate Cancers

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Tumor Biology

• Publication date

  2005-01-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000089290PMID 16254462
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [DNA methylation and cancer].

  2005cited by this paper
• DNA methylation and cancer.

  2004cited by this paper
• DNA Methylation as a Cancer‐Specific Biomarker

  2003cited by this paper
• DNA methylation as a cancer-specific biomarker: from molecules to populations.

  2003cited by this paper
• Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers.

  2003cited by this paper
• The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.

  2003cited by this paper
• Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers

  2002cited by this paper
• Aberrant DNA methylation in cancer: potential clinical interventions

  2002cited by this paper
• Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.

  2001cited by this paper
• The new human tissue kallikrein gene family: structure, function, and association to disease.

  2001cited by this paper
• Tumor progression: defining the soil round the tumor seed.

  2001cited by this paper
• Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue

  2001cited by this paper
• Role of DNA Methylation and Histone Acetylation in Steroid Receptor Expression in Breast Cancer

  2001cited by this paper
• Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues.

  2001cited by this paper
• Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer.

  2001cited by this paper
• CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression.

  2001cited by this paper
• The new human kallikrein gene family: implications in carcinogenesis.

  2000cited by this paper
• DNA methylation and cancer

  2000cited by this paper
• Large-scale human promoter mapping using CpG islands

  2000cited by this paper
• Matrix metalloproteinases: biologic activity and clinical implications.

  2000cited by this paper
• MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers.

  1999cited by this paper
• Cancer biology: extracellular proteinases in malignancy.

  1999cited by this paper
• Cancer-epigenetics comes of age

  1999cited by this paper
• The role for NES1 serine protease as a novel tumor suppressor.

  1998cited by this paper
• Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.

  1998cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996influential reference
• Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression.

  1996cited by this paper
• Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas.

  1995cited by this paper
• Tumor markers in the management of patients with ovarian cancer.

  1995cited by this paper
• 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

  1995cited by this paper
• Molecular aspects of tumor cell invasion and metastasis

  1993cited by this paper
• Tumor suppressor genes: the puzzle and the promise.

  1989cited by this paper
• CpG islands in vertebrate genomes.

  1987cited by this paper
• CpG-rich islands and the function of DNA methylation

  1986cited by this paper
• Hypomethylation of DNA from benign and malignant human colon neoplasms.

  1985cited by this paper
• Plasminogen activators, tissue degradation, and cancer.

  1985cited by this paper
• Molecular, cellular and animal pharmacology of 5-aza-2'-deoxycytidine.

  1985cited by this paper
• Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells.

  1982cited by this paper

• Remodeling of the extracellular matrix by serine proteases as a prerequisite for cancer initiation and progression.

  2024cites this paper
• Kallikrein-related peptidases: mechanistic understanding for potential therapeutic targeting in cancer

  2024cites this paper
• MicroRNA-141-regulated KLK10 and TNFSF-15 gene expression in hepatoblastoma cells as a novel mechanism in liver carcinogenesis

  2024cites this paper
• Inflammatory proteins and neutrophil extracellular traps increase in burn blister fluid 24h after burn.

  2024cites this paper
• Multidimensional outlook on the pathophysiology of cervical cancer invasion and metastasis

  2023cites this paper
• Prospective quantitative gene expression analysis of kallikrein-related peptidase KLK10 as a diagnostic biomarker for childhood acute lymphoblastic leukemia

  2022cites this paper
• MiR-194-3p modulates the progression of colorectal cancer by targeting KLK10.

  2021cites this paper
• Stable flow-induced expression of KLK10 inhibits endothelial inflammation and atherosclerosis

  2021cites this paper
• KLK10 exon 3 unmethylated PCR product concentration: a new potential early diagnostic marker in ovarian cancer? - A pilot study

  2018cites this paper
• Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer

  2018cites this paper
• Alterations of the epigenome in brain cancer: loss of 5-hydroxymethylcytosine

  2017cites this paper
• Kallikrein-related peptidases (KLKs) and the hallmarks of cancer

  2016cites this paper
• Upregulated KLK10 inhibits esophageal cancer proliferation and enhances cisplatin sensitivity in vitro.

  2015cites this paper
• NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells

  2015cites this paper
• Characterization of Changes in Global Genes Expression in the Distal Colon of Loperamide-Induced Constipation SD Rats in Response to the Laxative Effects of Liriope platyphylla

  2015cites this paper
• Human Kallikrein 10 Expression in Surgically Removed Human Pituitary Corticotroph Adenomas: An Immunohistochemical Study

  2015cites this paper
• Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival

  2015cites this paper
• Epigenetic Analysis of the Kallikrein Gene Family and Associated Pathways as a Novel Panel of Prostate Cancer Biomarkers

  2015cites this paper
• Assessment of kallikrein-related peptidases 4 and 6 (KLK4 and KLK6) as candidate biomarkers in prostate and ovarian cancer

  2015cites this paper
• Exploring breast carcinogenesis through integrative genomics and epigenomics analyses.

  2014cites this paper
• Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma

  2014cites this paper
• KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patients.

  2014cites this paper
• Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers

  2014cites this paper
• Human Tissue Kallikrein 10

  2013cites this paper
• Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies

  2013cites this paper
• Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.

  2013cites this paper
• The Impact of Chromosomal Aberrations on the Regulation of Kallikrein 6 Expression in Serous Ovarian Carcinoma

  2013influential citation
• Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies

  2013cites this paper
• Structural basis of DNA binding complexes

  2013cites this paper
• Kallikrein-related peptidase 10 expression in salivary gland tissues and tumours

  2012cites this paper
• Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there

  2012cites this paper
• The miRNA-kallikrein axis of interaction: a new dimension in the pathogenesis of prostate cancer

  2012cites this paper
• Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer

  2012cites this paper
• Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As(2)O(3) and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3/AsR.

  2012cites this paper
• The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6)

  2012cites this paper
• Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers

  2012cites this paper
• Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patients

  2012cites this paper
• Solution structure and dynamic analysis of chicken MBD2 methyl binding domain bound to a target-methylated DNA sequence

  2011cites this paper
• Genomic instability and copy‐number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas

  2011cites this paper
• Kallikreins 5, 6 and 10 Differentially Alter Pathophysiology and Overall Survival in an Ovarian Cancer Xenograft Model

  2011cites this paper
• KLK10 (kallikrein-related peptidase 10)

  2011cites this paper
• Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer.

  2011cites this paper
• 14 Kinins: kallikreins and kinins in cancer

  2011cites this paper
• Genes Associated with Recurrence of Hepatocellular Carcinoma: Integrated Analysis by Gene Expression and Methylation Profiling

  2011cites this paper
• Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non‐small cell lung cancer

  2010cites this paper
• Cellular Proteases as Cancer Biomarkers: A Review

  2010cites this paper
• Kallikrein-Related Peptidase 10 (KLK10) Expression and Single Nucleotide Polymorphisms in Ovarian Cancer Survival

  2010cites this paper
• The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer

  2009cites this paper
• Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer.

  2009cites this paper
• Lupeol inhibits proliferation of human prostate cancer cells by targeting beta-catenin signaling.

  2009cites this paper
• Distribution of Human Tissue Kallikrein-Related Peptidases in Tissues and Biological Fluids: Localization, Hormonal Regulation and Physiological Functions in the Female Reproductive System

  2009cites this paper
• Kallikrein 10 ( KLK 10 ) methylation as a novel prognostic biomarker in early breast cancer

  2009cites this paper
• Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer

  2008cites this paper
• Involvement of Chymotrypsin-Like Serine Proteases in Cell Death Processes

  2008cites this paper
• Breast cancer epigenetics: normal human mammary epithelial cells as a model system

  2008influential citation
• Androgens act synergistically to enhance estrogen‐induced upregulation of human tissue kallikreins 10, 11, and 14 in breast cancer cells via a membrane bound androgen receptor

  2008cites this paper
• Glucocorticoid receptor-mediated expression of kallikrein 10 in human breast cancer cell lines

  2007cites this paper
• New insights into the functional mechanisms and clinical applications of the kallikrein‐related peptidase family

  2007cites this paper
• DNA methylation in breast and colorectal cancers

  2007cites this paper
• Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer.

  2007cites this paper
• A novel application of melting curves: utility of peak area calculation for relative methylation quantification

  2007cites this paper
• Human kallikrein 10 ELISA development and validation in breast cancer sera.

  2007cites this paper
• Human tissue kallikreins : The cancer biomarker family q

  2007cites this paper
• Human tissue kallikreins: the cancer biomarker family.

  2007cites this paper
• Downregulation and CpG island hypermethylation of NES1/hK10 gene in the pathogenesis of human gastric cancer.

  2007cites this paper
• A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy

  2007cites this paper
• The human kallikrein 10 promoter contains a functional retinoid response element

  2006cites this paper
• The kallikrein world: an update on the human tissue kallikreins

  2006cites this paper
• Characterization of Human Kallikreins 6 and 10 in Ascites Fluid from Ovarian Cancer Patients

  2006cites this paper
• Human kallikrein 10, a predictive marker for breast cancer

  2006cites this paper
• The epigenetic basis for the aberrant expression of kallikreins in human cancers

  2006cites this paper
• World Journal of Clinical Oncology

  year unknowncites this paper